REVOLAX™ FINE

It penetrates quickly into the skin, creating a very natural and healthier look for the injected area.

REVOLAX™ Fine is designed for the treatment of superficial wrinkles, including crow’s feet, frown lines, and neck wrinkles.

REVOLAX™ FINE Dermal Filler is a cross-linked hyaluronic acid technology, in the form of a thick and durable gel with high viscoelasticity and plastic consistency.

• Reduces fine lines
• Corrects the eye area
• Fills so-called “crow’s feet”
• Corrects wrinkles on the forehead, around the mouth, and on the neck

• REVOLAX™ FINE without lidocaine is recommended for intradermal implantation for volume loss and morphological asymmetry of the face.
• The area to be treated must be carefully disinfected, and the product must be injected under sterile conditions.
• Keep the product at room temperature for 30 minutes before injection.
• Before injecting, press the plunger of the needle down until a small drop is visible at the end of the needle.
• Inject slowly into the dermis using the appropriate technique, either the linear threading technique or a series of spot injections with the syringe provided.
• The amount of REVOLAX™ FINE to be injected per wrinkle will depend on its severity.
• If whitening is observed, that is if the skin turns white, the injection must be stopped immediately, and the area massaged until it returns to its normal color.
• After the injection, the correction area should be lightly massaged to conform to the surrounding tissue.
• Touch-up of a correction started with REVOLAX™ FINE should be done immediately or within a few weeks after the first injection.

Contraindications:

• Do not inject REVOLAX™ FINE into the eye area (eye circle or eyelids).
• Do not inject REVOLAX™ FINE into the blood vessels (intravascular).
• REVOLAX™ FINE should not be used in:
• Pregnant or nursing women
• Persons under 18 years of age
• Patients known to be hypersensitive to hyaluronic acid
• Patients who tend to develop hypertrophic scars
• REVOLAX™ FINE should not be used in areas with inflammatory and infectious skin problems.

After-care:

• Do not use it in patients with coagulation disorders or in patients who have been treated with thrombolytic anticoagulants or platelet aggregation inhibitors within the previous 2 weeks.
• Also, it is recommended to avoid taking aspirin, non-steroidal anti-inflammatory drugs, or high doses of vitamin C the week before the injection.
• Patients are advised not to wear makeup for 12 hours after the injection and to avoid extended exposure to sunlight, UV light, and extreme cold and heat for 2 weeks after the injection.